Charles McGrath
Steering Committee Member

I’m Charles McGrath, a survivor of acute myeloid leukaemia (AML). I was diagnosed in September 2022 and underwent four rounds of intensive chemotherapy. I have shared my journey on social media and, in recent months, have become more involved in patient advocacy.

My aims as a patient advocate are to highlight the particular impact acute leukaemia has on AYA patients, including on mental and sexual health; to emphasise the need for kinder treatments for acute leukaemia patients; and to encourage medical professionals to engage with patients more readily when compiling studies and developing new therapies.